Recent from talks
Bipartisan Commission on Biodefense
Knowledge base stats:
Talk channels stats:
Members stats:
Bipartisan Commission on Biodefense
The Bipartisan Commission on Biodefense, formerly known as the Blue Ribbon Study Panel on Biodefense, is an organization of former high-ranking government officials that analyzes US capabilities and capacity to defend against biological threats. According to the commission's mission statement, the organization was formed to "provide for a comprehensive assessment of the state of U.S. biodefense efforts, and to issue recommendations that will foster change."
The commission is supported by donor organizations. New Venture Fund serves as the commission's fiscal sponsor. Current donors include Open Philanthropy and Bavarian Nordic.
The Bipartisan Commission on Biodefense is co-chaired by former secretary of homeland security and governor Tom Ridge and former secretary of health and human services Donna Shalala. Former senator Joe Lieberman co-chaired the commission with Governor Ridge prior to his death in 2024.
Sources:
Between 2001 and 2014, the U.S. spent around $80 billion on biodefense. Beginning in fall 2014, the Bipartisan Commission on Biodefense conducted meetings, interviews, and research. It studied the 2001 anthrax attacks and biodefense programs undertaken during the Clinton, Bush, and Obama Administrations.
In October 2015, the commission released its recommendations to publicly and submitted them to Congress in the form of the report, A National Blueprint for Biodefense: Leadership and Major Reform Needed to Optimize Efforts. They concluded that the United States was not prepared to respond to a large scale biological event - naturally occurring, accidentally released, or intentionally introduced. As for the cause of the problem, the report said, "Simply put, the Nation does not afford the biological threat the same level of attention as it does other threats."
The Bipartisan Commission on Biodefense conducted a year-long study of how the U.S. should address biological threats. The study covered human-generated (i.e., terrorism, warfare, accidents) and naturally occurring biological threats. The study culminated in a report to the public and Congress released on October 28, 2015.
The group's report was titled A National Blueprint for Biodefense. The report described many biological threats, including those posed by the Islamic State and Al Qaeda, as well as nation states, and "mishandling of lethal biological agents by the U.S. government," as reasons for making biodefense a high national priority. This report contained 33 recommendations and 87 specific action items associated with those recommendations.
Hub AI
Bipartisan Commission on Biodefense AI simulator
(@Bipartisan Commission on Biodefense_simulator)
Bipartisan Commission on Biodefense
The Bipartisan Commission on Biodefense, formerly known as the Blue Ribbon Study Panel on Biodefense, is an organization of former high-ranking government officials that analyzes US capabilities and capacity to defend against biological threats. According to the commission's mission statement, the organization was formed to "provide for a comprehensive assessment of the state of U.S. biodefense efforts, and to issue recommendations that will foster change."
The commission is supported by donor organizations. New Venture Fund serves as the commission's fiscal sponsor. Current donors include Open Philanthropy and Bavarian Nordic.
The Bipartisan Commission on Biodefense is co-chaired by former secretary of homeland security and governor Tom Ridge and former secretary of health and human services Donna Shalala. Former senator Joe Lieberman co-chaired the commission with Governor Ridge prior to his death in 2024.
Sources:
Between 2001 and 2014, the U.S. spent around $80 billion on biodefense. Beginning in fall 2014, the Bipartisan Commission on Biodefense conducted meetings, interviews, and research. It studied the 2001 anthrax attacks and biodefense programs undertaken during the Clinton, Bush, and Obama Administrations.
In October 2015, the commission released its recommendations to publicly and submitted them to Congress in the form of the report, A National Blueprint for Biodefense: Leadership and Major Reform Needed to Optimize Efforts. They concluded that the United States was not prepared to respond to a large scale biological event - naturally occurring, accidentally released, or intentionally introduced. As for the cause of the problem, the report said, "Simply put, the Nation does not afford the biological threat the same level of attention as it does other threats."
The Bipartisan Commission on Biodefense conducted a year-long study of how the U.S. should address biological threats. The study covered human-generated (i.e., terrorism, warfare, accidents) and naturally occurring biological threats. The study culminated in a report to the public and Congress released on October 28, 2015.
The group's report was titled A National Blueprint for Biodefense. The report described many biological threats, including those posed by the Islamic State and Al Qaeda, as well as nation states, and "mishandling of lethal biological agents by the U.S. government," as reasons for making biodefense a high national priority. This report contained 33 recommendations and 87 specific action items associated with those recommendations.